Free Trial

Nihon Kohden Corporation (OTCMKTS:NHNKY) Short Interest Update

Nihon Kohden logo with Medical background

Key Points

  • Nihon Kohden Corporation's short interest surged by 325.0% in July, reaching a total of 6,800 shares compared to 1,600 shares at the end of June.
  • The company reported a net margin of 6.23% and $0.18 EPS for the last quarter, with revenues amounting to $439.11 million.
  • Nihon Kohden's stock is currently trading at $11.59, with a one-year price range between $9.86 and $17.28.
  • Interested in Nihon Kohden? Here are five stocks we like better.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totaling 6,800 shares, agrowthof325.0% from the June 30th total of 1,600 shares. Based on an average daily trading volume, of 12,000 shares, the short-interest ratio is presently 0.6 days. Based on an average daily trading volume, of 12,000 shares, the short-interest ratio is presently 0.6 days.

Nihon Kohden Price Performance

Shares of Nihon Kohden stock opened at $11.59 on Friday. Nihon Kohden has a one year low of $9.86 and a one year high of $17.28. The firm has a market capitalization of $1.98 billion, a price-to-earnings ratio of 20.70 and a beta of 0.35. The business has a 50-day simple moving average of $12.17 and a 200 day simple moving average of $13.17.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported $0.18 EPS for the quarter. Nihon Kohden had a return on equity of 7.20% and a net margin of 6.23%. The business had revenue of $439.11 million during the quarter.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nihon Kohden Right Now?

Before you consider Nihon Kohden, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.

While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines